For instance, in breast cancer, raised levels of PRC2 leads to high levels H3K27 methylation in the promoter regions of FOXC1, E-cadherin, RAD51, RUNX3 and CDKN1C (p57kip2) [71]. Here, RUNX3 is linked to breast carcinoma.